Fosun Pharma Invests $46 Million in US Nutritional Company; Forms JV

Shanghai Fosun Pharma will make a $46.3 million investment in Nature's Sunshine Products, a US maker of nutritional and personal care products. Fosun will own 15% of Nature’s Sunshine after completing the investment. The two companies will also form a drug distribution JV to distribute Nature’s Sunshine’s products in China by placing them in Fosun’s retail outlets and by direct mail. Nature's Sunshine will own 80% of the JV, investing $16 million initially, and Fosun will pay $4 million for a 20% stake. More details.... Stock Symbols: (SHA: 600196; HK: 2196) (NSDQ: NATR) Share this with colleagues: // //